Steven F. Baker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Steven F. Baker has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Luis Martinez-Sobrido
Texas Biomedical Research Institute, San Antonio, TX 78227, USA
18 shared publications - Aitor Nogales
Center for Animal Health Research, CISA-INIA-CSIC, Madrid, Spain
10 shared publications - Andrew Mehle
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison
6 shared publications David J. Topham
Department of Microbiology and Immunology, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, United States
6 shared publications- Himadri Nath
CSIR-Indian Institute of Chemical Biology
3 shared publications Joshua T. Mann
Infectious disease Program, Lovelace Biomedical Research Institute
3 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (10)
The factory enters the fray: how mitochondrial protein trafficking shapes the host response to infection
Beyond textbook functions in homeostatic metabolism, mitochondria are now recognized as central coordinators of cell-intrinsic and cell-extrinsic immune responses to infection. Directed trafficking of proteins and other molecules between mitochondria and the rest of the cell underlies a growing catalog of these activities. Some are pro-host; others are antagonized by viral effectors or co-opted by viruses entirely. How host and viral factors rewire the mitochondrial proteome during infection to shape these outcomes remains incompletely understood. The evolutionary history of this system adds another dimension: mitochondria retain biochemical signatures of their α-proteobacterial endosymbiotic origin, and ongoing co-evolution between viral, host, and mitochondrial genomes continues to shape the proteins that traffic to and from the organelle. Using published examples, we highlight general principles, mechanisms, and consequences of host and viral protein localization to and from the mitochondria. To support discovery, we present integrated gene lists identifying host mitochondrial factors with evidence for type I interferon stimulation, interactions with viral proteins, and signatures of positive selection. Together, these resources and the principles within offer a framework for understanding mitochondria not as passive metabolic machinery but as actively contested cellular territory whose protein composition is continuously negotiated between the host and the pathogen.
- 20 October 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (10)
Open AccessThe factory enters the fray: how mitochondrial protein trafficking shapes the host response to infection
Beyond textbook functions in homeostatic metabolism, mitochondria are now recognized as central coordinators of cell-intrinsic and cell-extrinsic immune responses to infection. Directed trafficking of proteins and other molecules between mitochondria and the rest of the cell underlies a growing catalog of these activities. Some are pro-host; others are antagonized by viral effectors or co-opted by viruses entirely. How host and viral factors rewire the mitochondrial proteome during infection to shape these outcomes remains incompletely understood. The evolutionary history of this system adds another dimension: mitochondria retain biochemical signatures of their α-proteobacterial endosymbiotic origin, and ongoing co-evolution between viral, host, and mitochondrial genomes continues to shape the proteins that traffic to and from the organelle. Using published examples, we highlight general principles, mechanisms, and consequences of host and viral protein localization to and from the mitochondria. To support discovery, we present integrated gene lists identifying host mitochondrial factors with evidence for type I interferon stimulation, interactions with viral proteins, and signatures of positive selection. Together, these resources and the principles within offer a framework for understanding mitochondria not as passive metabolic machinery but as actively contested cellular territory whose protein composition is continuously negotiated between the host and the pathogen.
- Open Access
Mapping global transcript isoform landscapes of influenza A virus infection and interferon stimulation reveals RNA-binding protein networks associated with immune remodeling
Infected cells rapidly adapt their transcriptional profile to upregulate genes that limit pathogen replication and promote inflammation. Viruses also induce widespread changes in host gene expression, and both host and virus further remodel the transcriptome through targeted mRNA degradation, modulation of alternative splicing, and alterations at transcript 5’ and 3’ ends. The complexity of the response to infection makes it difficult to understand which transcriptional changes are driven by the virus and which reflect the host antiviral program. Short-read RNA sequencing has been the primary tool for studying these changes, but its inability to resolve fulllength transcript isoforms limits isoform switching-based analyses, narrowing our understanding of how transcript usage shapes immunity. Here we profiled the host transcriptome in response to interferon-β treatment or influenza A virus infection using both short- and long-read RNA sequencing analyzed with the SQANTI3 pipeline. Because isoform switching and transcript abundance change are distinct regulatory events, we focused our analysis on differential transcript usage to uncover a layer of transcriptome remodeling that standard expression analysis cannot detect. Pathway analysis revealed distinct regulons for genes undergoing transcriptional upregulation compared with those undergoing isoform switching. These data provide a rich resource for querying the isoform changes underlying shared and distinct transcriptional programs triggered by viral infection or innate immune stimulation. To identify putative mechanisms coordinating these stimulation-dependent isoform changes, we integrated 232 eCLIP datasets and found a small set of RNA-binding proteins localized at these isoform switches, including DDX3X. Comparing the responses to interferon and to virus highlighted RNA-binding proteins associated with infection-dependent immune remodeling. Altogether, these results demonstrate the value of hybrid sequencing for deciphering the post-transcriptional regulatory code active during the antiviral response.
Open AccessMapping global transcript isoform landscapes of influenza A virus infection and interferon stimulation reveals RNA-binding protein networks associated with immune remodeling
Infected cells rapidly adapt their transcriptional profile to upregulate genes that limit pathogen replication and promote inflammation. Viruses also induce widespread changes in host gene expression, and both host and virus further remodel the transcriptome through targeted mRNA degradation, modulation of alternative splicing, and alterations at transcript 5’ and 3’ ends. The complexity of the response to infection makes it difficult to understand which transcriptional changes are driven by the virus and which reflect the host antiviral program. Short-read RNA sequencing has been the primary tool for studying these changes, but its inability to resolve fulllength transcript isoforms limits isoform switching-based analyses, narrowing our understanding of how transcript usage shapes immunity. Here we profiled the host transcriptome in response to interferon-β treatment or influenza A virus infection using both short- and long-read RNA sequencing analyzed with the SQANTI3 pipeline. Because isoform switching and transcript abundance change are distinct regulatory events, we focused our analysis on differential transcript usage to uncover a layer of transcriptome remodeling that standard expression analysis cannot detect. Pathway analysis revealed distinct regulons for genes undergoing transcriptional upregulation compared with those undergoing isoform switching. These data provide a rich resource for querying the isoform changes underlying shared and distinct transcriptional programs triggered by viral infection or innate immune stimulation. To identify putative mechanisms coordinating these stimulation-dependent isoform changes, we integrated 232 eCLIP datasets and found a small set of RNA-binding proteins localized at these isoform switches, including DDX3X. Comparing the responses to interferon and to virus highlighted RNA-binding proteins associated with infection-dependent immune remodeling. Altogether, these results demonstrate the value of hybrid sequencing for deciphering the post-transcriptional regulatory code active during the antiviral response.
- Open Access
RNAquarium: an archive-scale atlas of zebrafish gene expression coupled with pan-taxonomic profiling reveals diverse viral drivers of transcriptomic states
SUMMARY: Zebrafish RNA-seq studies span diverse developmental, physiological, and disease contexts, yet most analyses remain confined to individual experiments and disregard the non-zebrafish component of the data. We present RNAquarium, a scalable framework for joint transcriptomic and metatranscriptomic analysis of RNA-seq data and apply it to all publicly available zebrafish RNA-seq datasets in the Sequence Read Archive. RNAquarium captures transcriptomic structure across development and tissues, reveals diverse microbial and viral associations, and identifies previously undescribed zebrafish viruses including a close relative of human influenza B virus linked to distinct host transcriptional states. We further demonstrate that archive-scale transcriptomes can support foundation-model training and prediction of infection-associated transcriptomic signatures. RNAquarium provides an open framework and interactive portal for exploring the breadth of zebrafish gene expression patterns and associated taxa profiled across a large research community. Moreover, our framework establishes a generalizable strategy for integrating transcriptomic and metatranscriptomic analyses across the diversity of life represented in public sequencing archives.
Open AccessRNAquarium: an archive-scale atlas of zebrafish gene expression coupled with pan-taxonomic profiling reveals diverse viral drivers of transcriptomic states
SUMMARY: Zebrafish RNA-seq studies span diverse developmental, physiological, and disease contexts, yet most analyses remain confined to individual experiments and disregard the non-zebrafish component of the data. We present RNAquarium, a scalable framework for joint transcriptomic and metatranscriptomic analysis of RNA-seq data and apply it to all publicly available zebrafish RNA-seq datasets in the Sequence Read Archive. RNAquarium captures transcriptomic structure across development and tissues, reveals diverse microbial and viral associations, and identifies previously undescribed zebrafish viruses including a close relative of human influenza B virus linked to distinct host transcriptional states. We further demonstrate that archive-scale transcriptomes can support foundation-model training and prediction of infection-associated transcriptomic signatures. RNAquarium provides an open framework and interactive portal for exploring the breadth of zebrafish gene expression patterns and associated taxa profiled across a large research community. Moreover, our framework establishes a generalizable strategy for integrating transcriptomic and metatranscriptomic analyses across the diversity of life represented in public sequencing archives.
- Open Access
A novel ISG15 transcript restricts influenza A virus infection
SUMMARY: The interferon response orchestrates antiviral defense through the induction of interferon-stimulated genes (ISGs). Although nearly all human genes undergo alternative splicing, the identity and function of many ISG transcript isoforms remains poorly understood. Using long-read RNA sequencing of human cells that were undergoing an interferon response, we identified a previously unrecognized interferon-inducible ISG15 transcript. This non-canonical ISG15 (ncISG15) transcript contains a unique 5′ untranslated region and encodes an N-terminally truncated protein in frame with ISG15. During interferon stimulation, ncISG15 produces an ISGylation pattern distinct from canonical ISG15 and potently inhibits influenza A virus polymerase activity. The influenza A viral interferon antagonist protein NS1 counteracts ncISG15-mediated restriction; however, endogenous ncISG15 executes modest antiviral activity against NS1-encoding viruses. Antiviral activity of ncISG15 is largely independent of its function as a cytokine, through ISG augmentation, or by ISGylation. This novel transcript adds a new layer of regulatory complexity to the ISG15-driven antiviral network.
Open AccessA novel ISG15 transcript restricts influenza A virus infection
SUMMARY: The interferon response orchestrates antiviral defense through the induction of interferon-stimulated genes (ISGs). Although nearly all human genes undergo alternative splicing, the identity and function of many ISG transcript isoforms remains poorly understood. Using long-read RNA sequencing of human cells that were undergoing an interferon response, we identified a previously unrecognized interferon-inducible ISG15 transcript. This non-canonical ISG15 (ncISG15) transcript contains a unique 5′ untranslated region and encodes an N-terminally truncated protein in frame with ISG15. During interferon stimulation, ncISG15 produces an ISGylation pattern distinct from canonical ISG15 and potently inhibits influenza A virus polymerase activity. The influenza A viral interferon antagonist protein NS1 counteracts ncISG15-mediated restriction; however, endogenous ncISG15 executes modest antiviral activity against NS1-encoding viruses. Antiviral activity of ncISG15 is largely independent of its function as a cytokine, through ISG augmentation, or by ISGylation. This novel transcript adds a new layer of regulatory complexity to the ISG15-driven antiviral network.
- Open Access
- 6 January 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (1) , e0277225
Tandem split-GFP influenza A viruses for sensitive and accurate replication analyses
Reporter influenza A viruses (IAVs) are valuable tools for studying virus fitness, screening antivirals, and assessing host–virus interactions. However, the compact and segmented nature of the IAV genome presents major challenges for engineering genetically stable reporter viruses with minimal fitness defects. To address this, we developed a replication-competent IAV incorporating a tandem split-GFP reporter strategy. Specifically, we appended seven tandem repeats of the GFP11 peptide (GFP11×7) to the C-terminus of the PB2 or PA polymerase subunit. Viruses either contained or lacked a self-cleaving 2A peptide between the viral and reporter genes, thereby creating polymerase fusion proteins or released GFP, respectively. These viruses are complemented in trans by cells expressing GFP1-10, allowing bright fluorescence with minimal disruption to viral function. The tandem GFP11 reporter viruses exhibit delayed replication kinetics but are genetically stable over serial passages with a strong concordance between GFP signal and viral gene expression. We demonstrate their utility in high-throughput applications including fluorescence-based quantification of infection, neutralizing antibody titration, antiviral drug screening, and host factor identification, with results matching traditional assays but on an accelerated timeline. Furthermore, we engineered a battery of GFP1-10-expressing cell lines from multiple vertebrate species, illustrating the broad compatibility of this platform for comparative host studies. This system enables sensitive, scalable, and quantitative evaluation of influenza virus replication across diverse experimental contexts. The GFP11×7 reporter platform offers a versatile and robust tool for virology research and therapeutic screening, with potential for rapid adaptation to emerging IAV strains. IMPORTANCE: This study presents a refined approach for tracking influenza A virus infections using a bright fluorescent signal, minimizing the effects on viral function or stability. Influenza A virus has a compact genome that makes it difficult to insert reporter tags without disrupting its replication. By using a small, split fluorescent protein tag and a self-cleaving linker, we developed a virus that retains replication ability and accurately reports infection through fluorescence. This allows for monitoring of viral infection in living cells or fixed cells using standard laboratory tools. The system enables rapid screening of antiviral drugs, neutralizing antibodies, and host factors that contribute to infection, and it works in cells from multiple animal species. As a result, this tool can be used to study how influenza A virus replicates and spreads, supporting efforts in antiviral development, cross-species transmission research, and pandemic preparedness.
- 6 January 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (1) , e0277225
Open AccessTandem split-GFP influenza A viruses for sensitive and accurate replication analyses
Reporter influenza A viruses (IAVs) are valuable tools for studying virus fitness, screening antivirals, and assessing host–virus interactions. However, the compact and segmented nature of the IAV genome presents major challenges for engineering genetically stable reporter viruses with minimal fitness defects. To address this, we developed a replication-competent IAV incorporating a tandem split-GFP reporter strategy. Specifically, we appended seven tandem repeats of the GFP11 peptide (GFP11×7) to the C-terminus of the PB2 or PA polymerase subunit. Viruses either contained or lacked a self-cleaving 2A peptide between the viral and reporter genes, thereby creating polymerase fusion proteins or released GFP, respectively. These viruses are complemented in trans by cells expressing GFP1-10, allowing bright fluorescence with minimal disruption to viral function. The tandem GFP11 reporter viruses exhibit delayed replication kinetics but are genetically stable over serial passages with a strong concordance between GFP signal and viral gene expression. We demonstrate their utility in high-throughput applications including fluorescence-based quantification of infection, neutralizing antibody titration, antiviral drug screening, and host factor identification, with results matching traditional assays but on an accelerated timeline. Furthermore, we engineered a battery of GFP1-10-expressing cell lines from multiple vertebrate species, illustrating the broad compatibility of this platform for comparative host studies. This system enables sensitive, scalable, and quantitative evaluation of influenza virus replication across diverse experimental contexts. The GFP11×7 reporter platform offers a versatile and robust tool for virology research and therapeutic screening, with potential for rapid adaptation to emerging IAV strains. IMPORTANCE: This study presents a refined approach for tracking influenza A virus infections using a bright fluorescent signal, minimizing the effects on viral function or stability. Influenza A virus has a compact genome that makes it difficult to insert reporter tags without disrupting its replication. By using a small, split fluorescent protein tag and a self-cleaving linker, we developed a virus that retains replication ability and accurately reports infection through fluorescence. This allows for monitoring of viral infection in living cells or fixed cells using standard laboratory tools. The system enables rapid screening of antiviral drugs, neutralizing antibodies, and host factors that contribute to infection, and it works in cells from multiple animal species. As a result, this tool can be used to study how influenza A virus replicates and spreads, supporting efforts in antiviral development, cross-species transmission research, and pandemic preparedness.
- Open Access
Tandem split-GFP influenza A viruses for sensitive and accurate replication analyses
Reporter influenza A viruses (IAVs) are valuable tools for studying virus fitness, screening antivirals, and assessing host-virus interactions. However, the compact and segmented nature of the IAV genome presents major challenges for engineering genetically stable reporter viruses with minimal fitness defects. To address this, we developed a replication-competent IAV incorporating a tandem split-GFP reporter strategy. Specifically, we appended seven tandem repeats of the GFP11 peptide (GFP11×7) to the C-terminus of the PB2 or PA polymerase subunit. Viruses contained or lacked a self-cleaving 2A peptide between the viral and reporter genes to create polymerase fusion proteins or released GFP, respectively. These viruses are complemented in trans by cells expressing GFP1-10, allowing bright fluorescence with minimal disruption to viral function. The tandem GFP11 reporter viruses exhibit delayed replication kinetics, but are genetically stable over serial passages with a strong concordance between GFP signal and viral gene expression. We demonstrate their utility in high-throughput applications including fluorescence-based quantification of infection, neutralizing antibody titration, antiviral drug screening, and host factor identification, with results matching traditional assays but on an accelerated timeline. Furthermore, we engineered a battery of GFP1-10-expressing cell lines from multiple vertebrate species, illustrating the broad compatibility of this platform for comparative host studies. This system enables sensitive, scalable, and quantitative evaluation of influenza virus replication across diverse experimental contexts. The GFP11×7 reporter platform offers a versatile and robust tool for virology research and therapeutic screening, with potential for rapid adaptation to emerging IAV strains.
Open AccessTandem split-GFP influenza A viruses for sensitive and accurate replication analyses
Reporter influenza A viruses (IAVs) are valuable tools for studying virus fitness, screening antivirals, and assessing host-virus interactions. However, the compact and segmented nature of the IAV genome presents major challenges for engineering genetically stable reporter viruses with minimal fitness defects. To address this, we developed a replication-competent IAV incorporating a tandem split-GFP reporter strategy. Specifically, we appended seven tandem repeats of the GFP11 peptide (GFP11×7) to the C-terminus of the PB2 or PA polymerase subunit. Viruses contained or lacked a self-cleaving 2A peptide between the viral and reporter genes to create polymerase fusion proteins or released GFP, respectively. These viruses are complemented in trans by cells expressing GFP1-10, allowing bright fluorescence with minimal disruption to viral function. The tandem GFP11 reporter viruses exhibit delayed replication kinetics, but are genetically stable over serial passages with a strong concordance between GFP signal and viral gene expression. We demonstrate their utility in high-throughput applications including fluorescence-based quantification of infection, neutralizing antibody titration, antiviral drug screening, and host factor identification, with results matching traditional assays but on an accelerated timeline. Furthermore, we engineered a battery of GFP1-10-expressing cell lines from multiple vertebrate species, illustrating the broad compatibility of this platform for comparative host studies. This system enables sensitive, scalable, and quantitative evaluation of influenza virus replication across diverse experimental contexts. The GFP11×7 reporter platform offers a versatile and robust tool for virology research and therapeutic screening, with potential for rapid adaptation to emerging IAV strains.
- 2 February 2023
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 146, 40-56
All differential on the splicing front: Host alternative splicing alters the landscape of virus-host conflict
- 2 February 2023
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 146, 40-56
All differential on the splicing front: Host alternative splicing alters the landscape of virus-host conflict
- Open Access
- 21 December 2022
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 20 (12) , e3001934
Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus
Viruses must balance their reliance on host cell machinery for replication while avoiding host defense. Influenza A viruses are zoonotic agents that frequently switch hosts, causing localized outbreaks with the potential for larger pandemics. The host range of influenza virus is limited by the need for successful interactions between the virus and cellular partners. Here we used immunocompetitive capture-mass spectrometry to identify cellular proteins that interact with human- and avian-style viral polymerases. We focused on the proviral activity of heterogenous nuclear ribonuclear protein U-like 1 (hnRNP UL1) and the antiviral activity of mitochondrial enoyl CoA-reductase (MECR). MECR is localized to mitochondria where it functions in mitochondrial fatty acid synthesis (mtFAS). While a small fraction of the polymerase subunit PB2 localizes to the mitochondria, PB2 did not interact with full-length MECR. By contrast, a minor splice variant produces cytoplasmic MECR (cMECR). Ectopic expression of cMECR shows that it binds the viral polymerase and suppresses viral replication by blocking assembly of viral ribonucleoprotein complexes (RNPs). MECR ablation through genome editing or drug treatment is detrimental for cell health, creating a generic block to virus replication. Using the yeast homolog Etr1 to supply the metabolic functions of MECR in MECR-null cells, we showed that specific antiviral activity is independent of mtFAS and is reconstituted by expressing cMECR. Thus, we propose a strategy where alternative splicing produces a cryptic antiviral protein that is embedded within a key metabolic enzyme.
- 21 December 2022
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 20 (12) , e3001934
Open AccessAlternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus
Viruses must balance their reliance on host cell machinery for replication while avoiding host defense. Influenza A viruses are zoonotic agents that frequently switch hosts, causing localized outbreaks with the potential for larger pandemics. The host range of influenza virus is limited by the need for successful interactions between the virus and cellular partners. Here we used immunocompetitive capture-mass spectrometry to identify cellular proteins that interact with human- and avian-style viral polymerases. We focused on the proviral activity of heterogenous nuclear ribonuclear protein U-like 1 (hnRNP UL1) and the antiviral activity of mitochondrial enoyl CoA-reductase (MECR). MECR is localized to mitochondria where it functions in mitochondrial fatty acid synthesis (mtFAS). While a small fraction of the polymerase subunit PB2 localizes to the mitochondria, PB2 did not interact with full-length MECR. By contrast, a minor splice variant produces cytoplasmic MECR (cMECR). Ectopic expression of cMECR shows that it binds the viral polymerase and suppresses viral replication by blocking assembly of viral ribonucleoprotein complexes (RNPs). MECR ablation through genome editing or drug treatment is detrimental for cell health, creating a generic block to virus replication. Using the yeast homolog Etr1 to supply the metabolic functions of MECR in MECR-null cells, we showed that specific antiviral activity is independent of mtFAS and is reconstituted by expressing cMECR. Thus, we propose a strategy where alternative splicing produces a cryptic antiviral protein that is embedded within a key metabolic enzyme.
- Open Access
CXCR4 controls movement and degranulation of CD8 + T cells in the influenza-infected lung via differential effects on interaction and tissue scanning
Effector CD8 + T cell interactions are critical in controlling viral infection by directly killing infected cells but overabundant or sustained activation also exacerbates tissue damage. Chemokines promote the trafficking of effector CD8 + T cells into infected tissues, but we know little about how chemokines regulate the function of CD8 + T cells within tissues. Using a murine model of influenza A virus infection, we found that expression of the chemokine receptor CXCR4 by lung-infiltrating cytotoxic T cells correlated with the expression of the degranulation marker CD107a. Inhibition of CXCR4 reduced activation, adhesion, and degranulation of cytotoxic T cells in vitro and in vivo . Moreover, in live influenza-infected lung tissue, T cells stopped moving in lung regions with high levels of influenza antigen, and CXCR4 was essential for CD8 + T cells to execute this arrest signal fully. In contrast, CXCR4 increased the motility of CD8 + T cells in low-influenza areas of the lung. We also found that CXCR4 stimulated the effector function of lung-infiltrating cytotoxic T cells even after clearance of influenza virus, and inhibition of CXCR4 expedited the recovery of influenza-infected mice, despite delayed clearance of the replication-competent virus. Our results suggest that CXCR4 promotes the interaction strength of cytotoxic T cells in lung tissue through combined effects on T cell movement and interaction with virally infected target cells in influenza infected-lungs.
Open AccessCXCR4 controls movement and degranulation of CD8 + T cells in the influenza-infected lung via differential effects on interaction and tissue scanning
Effector CD8 + T cell interactions are critical in controlling viral infection by directly killing infected cells but overabundant or sustained activation also exacerbates tissue damage. Chemokines promote the trafficking of effector CD8 + T cells into infected tissues, but we know little about how chemokines regulate the function of CD8 + T cells within tissues. Using a murine model of influenza A virus infection, we found that expression of the chemokine receptor CXCR4 by lung-infiltrating cytotoxic T cells correlated with the expression of the degranulation marker CD107a. Inhibition of CXCR4 reduced activation, adhesion, and degranulation of cytotoxic T cells in vitro and in vivo . Moreover, in live influenza-infected lung tissue, T cells stopped moving in lung regions with high levels of influenza antigen, and CXCR4 was essential for CD8 + T cells to execute this arrest signal fully. In contrast, CXCR4 increased the motility of CD8 + T cells in low-influenza areas of the lung. We also found that CXCR4 stimulated the effector function of lung-infiltrating cytotoxic T cells even after clearance of influenza virus, and inhibition of CXCR4 expedited the recovery of influenza-infected mice, despite delayed clearance of the replication-competent virus. Our results suggest that CXCR4 promotes the interaction strength of cytotoxic T cells in lung tissue through combined effects on T cell movement and interaction with virally infected target cells in influenza infected-lungs.
- Open Access
- 5 March 2022
- Published by ZappyLab, Inc.
Influenza virus plaque assay v1
Determine virus concentration from cell culture, lung homogenates, and more. This protocol measures virus in plaque forming units per ml solution. This protocol differs from classic flu plaque assays by using a semi-solid overlay (Avicel) as opposed to agarose. This is beneficial in avoiding reproducibility issues that can arise from burning monolayers with hot overlay, and is faster to make and aspirate. The negative is that you cannot plaque purify viral isolates as you can with agarose. Theoretically one infectious virion can spawn one plaque by initiating in a cell and infecting neighboring cells. This is the gold standard for virology, and for influenza, the plaque:particle ration is ~ 1:100. Thus there are lots of non/semi-infectious or defective interfering particles that are produced that are not on their own infectious.
- 5 March 2022
- Published by ZappyLab, Inc.
Open AccessInfluenza virus plaque assay v1
Determine virus concentration from cell culture, lung homogenates, and more. This protocol measures virus in plaque forming units per ml solution. This protocol differs from classic flu plaque assays by using a semi-solid overlay (Avicel) as opposed to agarose. This is beneficial in avoiding reproducibility issues that can arise from burning monolayers with hot overlay, and is faster to make and aspirate. The negative is that you cannot plaque purify viral isolates as you can with agarose. Theoretically one infectious virion can spawn one plaque by initiating in a cell and infecting neighboring cells. This is the gold standard for virology, and for influenza, the plaque:particle ration is ~ 1:100. Thus there are lots of non/semi-infectious or defective interfering particles that are produced that are not on their own infectious.